ACC 2026: sotatercept meta-analysis backs disease-modifying role in PAH

Thursday, April 2, 2026GlobalData HealthcareView original

New data presented at ACC 2026 clarifies sotatercept’s role alongside vasodilator-based regimens in PAH patients.

Read the full article on the original site.